The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 24, 2009

Filed:

Nov. 16, 2006
Applicants:

Swen Hoelder, Constance, DE;

Gunter Muller, Sulzbach, DE;

Karl Schoenafinger, Alzenau, DE;

David William Will, Kriftel, DE;

Hans Matter, Langenselbold, DE;

Martin Bossart, Frankfurt, DE;

Cecile Combeau, Fontenay aux Roses, FR;

Christine Delaisi, Saint Maur, FR;

Ingrid Sassoon, Villejuif, FR;

Anke Steinmetz, Vitry sur Seine, FR;

Didier Benard, Montsoult, FR;

Inventors:

Swen Hoelder, Constance, DE;

Gunter Muller, Sulzbach, DE;

Karl Schoenafinger, Alzenau, DE;

David William Will, Kriftel, DE;

Hans Matter, Langenselbold, DE;

Martin Bossart, Frankfurt, DE;

Cecile Combeau, Fontenay aux Roses, FR;

Christine Delaisi, Saint Maur, FR;

Ingrid Sassoon, Villejuif, FR;

Anke Steinmetz, Vitry sur Seine, FR;

Didier Benard, Montsoult, FR;

Assignee:

Aventis Pharma S.A., Antony, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/501 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 405/04 (2006.01); C07D 409/04 (2006.01); C07D 413/14 (2006.01); C07D 487/04 (2006.01); A61K 31/53 (2006.01); A61K 31/5355 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed are compounds according to the general formula (I), where the definitions of the substituents X, Rand Rare detailed in the description, as well as their physiologically acceptable salts and solvate, methods for producing these compounds and their use as pharmaceuticals. These compounds are kinase inhibitors, in particular inhibitors of the kinase CDK2 (cyclin-dependent kinase 2).


Find Patent Forward Citations

Loading…